Viewing Study NCT01462669


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-11 @ 3:15 AM
Study NCT ID: NCT01462669
Status: COMPLETED
Last Update Posted: 2018-06-19
First Post: 2011-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ezogabine View
None Pharmacokinetics View
None Retigabine View